Related Experiment Video
Updated: May 8, 2026
09:34
An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
Published on: August 16, 2021
Systems approaches to studying the immune response in tuberculosis
Matthew Paul Reddoch Berry1, Simon Blankley, Christine Marian Graham
1Division of Immunoregulation, MRC National Institute for Medical Research, London NW7 1AA, UK; Department of Respiratory Medicine, Imperial College Healthcare NHS Trust, St. Mary's Hospital, London W2 1NY, UK.
Current Opinion in Immunology
|September 12, 2013
Summary
Tuberculosis (TB) research using microarrays reveals that type I interferons may harm the host during infection. This finding has implications for developing new TB vaccines and treatments.
Area of Science:
- Microbiology
- Immunology
- Systems Biology
Background:
- Tuberculosis (TB) is a significant global health challenge causing substantial mortality and morbidity.
- Host transcriptional profiling offers insights into disease pathogenesis and potential therapeutic targets.
Purpose of the Study:
- To investigate the host response during TB using microarray analysis.
- To identify the role of specific immune pathways, such as type I interferons, in TB pathogenesis.
- To explore the utility of systems biology approaches for understanding complex infectious diseases.
Main Methods:
- Utilized microarray technology to analyze host transcriptional profiles during TB infection.
- Integrated data from experimental systems to corroborate findings.
- Identified candidate biomarkers for diagnosis and treatment monitoring.
Main Results:
- Highlighted a potentially detrimental role for type I interferons in host response during TB.
- Provided candidate biomarkers for advancing TB diagnosis and treatment monitoring.
Conclusions:
- Type I interferons may play a detrimental role in TB, suggesting new avenues for therapeutic intervention.
- Systems biology approaches, integrating transcriptional profiling, are promising for studying TB and other complex infectious diseases.
- Identified biomarkers could improve TB patient management.
Related Concept Videos
01:26Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
01:31Defense Against Bacterial Pathogens
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
01:28Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
01:29Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
01:28Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
01:31Pulmonary Tuberculosis III
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories: